Digirad Financial Ratios

Digirad Corporation -- USA Stock  

USD 2.34  0.04  1.74%

We urge you to utilize analysis of Digirad fundamentals to see if markets are presently mispricing the company. We found thirty-seven available fundamental indicators for Digirad Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Digirad fundamentals including its Shares Outstanding, Price to Sales, Cash per Share, as well as the relationship between Number of Shares Shorted and EBITDA . Please also check Digirad Corporation Price to Earning to verify the company can sustain itself down the road.Use Digirad to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Digirad to be traded at $2.57 in 30 days

Digirad Valuation Over Time

Enterprise Value

Digirad Company Summary

Digirad competes with Edwards Lifesciences, DarioHealth Corp. Digirad Corporation operates in two segments Diagnostic Services and Diagnostic Imaging. The Diagnostic Services segment offer inoffice nuclear cardiology and ultrasound services and cardiac event monitoring services to physicians who perform nuclear imaging echocardiography vascular or general ultrasound tests or any combination of these procedures in their offices hospitals and imaging centers. The Diagnostic Imaging segment sells nuclear imaging cameras for nuclear cardiology and general nuclear medicine applications as well as offer camera maintenance services to hospitals imaging centers physician offices and mobile service providers. Digirad Corporationration was founded in 1985 and is headquartered in Suwanee Georgia.

Digirad Current Asset vs Beta

Digirad Corporation is rated # 2 in current asset category among related companies. It is rated # 2 in beta category among related companies . The ratio of Current Asset to Beta for Digirad Corporation is about  14,766,047 

Digirad Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Digirad correlated with the market. If Beta is less then 0 Digirad generally moves in the opposite direction as compared to the market. If Digirad Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Digirad is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Digirad is generally in the same direction as the market. If Beta > 1 Digirad moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 47% 

Chance of Financial Distress

Digirad Corporation has less than 47 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Growth

Digirad Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth

Compare

Compare Digirad To Peers
Matt Molchan President CEO, Director
Jeffrey Eberwein Chairman of the Board, MBA
More Executives

Opportunity Range

December 12, 2017 Opportunity Range